ACP
Acuta Capital Partners’s Terns Pharmaceuticals TERN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73M | Buy |
463,864
+138,314
| +42% | +$516K | 2.42% | 15 |
|
|
2025
Q1 | $899K | Sell |
325,550
-121,950
| -27% | -$337K | 1.04% | 25 |
|
|
2024
Q4 | $2.48M | Sell |
447,500
-39,500
| -8% | -$219K | 2.49% | 15 |
|
|
2024
Q3 | $4.06M | Buy |
487,000
+117,720
| +32% | +$982K | 3.29% | 11 |
|
|
2024
Q2 | $2.51M | Sell |
369,280
-95,799
| -21% | -$652K | 2.12% | 19 |
|
|
2024
Q1 | $3.05M | Sell |
465,079
-90,181
| -16% | -$592K | 1.98% | 19 |
|
|
2023
Q4 | $3.6M | Hold |
555,260
| – | – | 2.03% | 21 |
|
|
2023
Q3 | $2.79M | Sell |
555,260
-414,740
| -43% | -$2.09M | 1.87% | 19 |
|
|
2023
Q2 | $8.49M | Sell |
970,000
-129,309
| -12% | -$1.13M | 5.75% | 3 |
|
|
2023
Q1 | $13M | Sell |
1,099,309
-691
| -0.1% | -$8.18K | 9.59% | 3 |
|
|
2022
Q4 | $11.2M | Buy |
1,100,000
+749,298
| +214% | +$7.63M | 6.89% | 4 |
|
|
2022
Q3 | $2.07M | Buy |
+350,702
| New | +$2.07M | 0.89% | 25 |
|